Table 3.

Outcome analysis of patients receiving cefoperazone-sulbactam versus piperacillin-tazobactam.

N = 324	Primary outcome		Secondary outcome		In-hospital mortality
	Crude OR (95% CI)	Adjust OR* (95% CI)	Crude OR (95% CI)	Adjust OR* (95% CI)	Crude OR (95% CI)	Adjust OR* (95% CI)
Reference = piperacillin-tazobactam
Cefoperazone-sulbactam	1.53 (1.02, 2.31)	1.53 (1.02, 2.31)	1.36 (0.89, 2.08)	1.36 (0.89, 2.08)	1.34 (0.90, 2.01)	1.34 (0.90, 2.01)

CI = confidence interval, OR = odds ratio.

^*Adjust OR by Wald method.